Interview with Michael J. Aminoff, M.D., Scott Pomeroy, M.D., Ph.D., and Kerry Levin, M.D.
How has The Netter Collection of Medical Illustrations: Nervous System, Volume 7, 3rd Edition since the previous edition? How has it evolved since the first edition?
Dr. Aminoff: It has been updated to include recent advances in molecular medicine, especially in genetics, immunology, and pharmacology, and the therapeutic benefits to which they have led. Compared to the first edition, technological advances in imaging have allowed us to incorporate CT and MR images to complement the anatomic pictures that are an important feature of the volumes.
Dr. Pomeroy: There have been dramatic advances for many nervous system diseases since the last edition.
What is the most exciting aspect of The Netter Collection of Medical Illustrations: Nervous System, Volume 7, 3rd Edition? What chapter or topic covered in the new edition are you most excited about?
Dr. Pomeroy: Advances in precision medicine, especially for neuromuscular diseases including spinal muscular atrophy.
Dr. Aminoff: The new edition adds attention to the current genetic, physiological, and immunological aspects of neurological disease.
Who will find the greatest value from The Netter Collection of Medical Illustrations: Nervous System, Volume 7, 3rd Edition and why? Has the audience changed since the book was first published?
Dr. Levin: This book will be of particular value to medical student and students of biology or neuroscience. It will also be appreciated by general medical and neurologic residents.
Dr. Aminoff: The new edition will also appeal to clinicians in practice as a concise update on the major neurological disorders.
Dr. Pomeroy: With outstanding illustrations and updated text, the books will be interesting to anyone interested in the nervous system and nervous system diseases.
What new ideas, practices, or procedures would you like to highlight for the new edition?
Dr. Pomeroy: Insights into the causes and mechanisms of nervous system diseases have enabled new therapies.
What problem do you hope the future generation of your specialty will be able to solve?
Dr. Levin: I expect that new genetic treatments will provide cures for various hereditary diseases, and that—as biomarkers of certain diseases become more apparent– various degenerative diseases will also finally be cured or, at the very least, become treatable before they become symptomatic.
Dr. Pomeroy: I hope cures for degenerative diseases and cancers will be found.
About the Authors
My name is Dr. Michael Aminoff and I am Professor Emeritus of Neurology at the School of Medicine at the University of California San Francisco.
I am Dr. Scott Pomeroy, Bronson Crothers Professor of Neurology at Harvard Medical School and Chair of the Department of Neurology of Boston Children’s Hospital.
My name is Dr. Kerry Levin, and I am a Professor of Neurology and Chairman of the Department of Neurology at Cleveland Clinic, Cleveland, Ohio.
Purchase your copy of